Jason Dorenfeld

Senior Financial Planning Analyst at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Jason Dorenfeld's Colleagues at Alnylam Pharmaceuticals
Delbar Elahi

Clinical Development Post-Doctoral Fellow

Contact Delbar Elahi

Loren Pete

Manager, Quality Standards and Compliance, GPSRM

Contact Loren Pete

Stephen Huang

Senior Director, Clinical Development

Contact Stephen Huang

Kenneth Petrella

Senior Manager, US Marketing

Contact Kenneth Petrella

View All Jason Dorenfeld's Colleagues
Jason Dorenfeld's Contact Details
HQ
(617) 551-8200
Location
Reading, Massachusetts
Company
Alnylam Pharmaceuticals
Jason Dorenfeld's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Jason Dorenfeld
Jason Dorenfeld currently works for Alnylam Pharmaceuticals.
Jason Dorenfeld's role at Alnylam Pharmaceuticals is Senior Financial Planning Analyst.
Jason Dorenfeld's email address is ***@alnylam.com. To view Jason Dorenfeld's full email address, please signup to ConnectPlex.
Jason Dorenfeld works in the SaaS industry.
Jason Dorenfeld's colleagues at Alnylam Pharmaceuticals are Delbar Elahi, Victoria Solomon, Loren Pete, Stephen Huang, Elizabeth Schofield, Kenneth Petrella, Kaitlyn Sullivan and others.
Jason Dorenfeld's phone number is (617) 551-8200
See more information about Jason Dorenfeld